From The Podium
For global meeting news
that affects your practice,
here are our latest offerings:
More

Resources from Industry

APEX Awards

ASHPE 2011 Award Winner

Cardiology Today Intervention Current Print Issue

The following articles appeared in the current print edition of Cardiology Today Intervention.

January/February 2012

FIRST IN MAN
DES: A Promising Future Strategy for ED
COVER STORY
First, Do No Harm
CUTTING EDGE
PCI Optimization Through Combined FFR, OCT Platform
BUSINESS NEWS
Maryland Cardiologist Given Sentence for Unnecessary StentingUnnecessary Procedures on Cutting Block for CMS ReimbursementAbbott to Separate Into Two Companies
REGULATORY NEWS
FDA Approves Transcatheter Valve for Patients with Inoperable ASBalloon-Expandable Stent Gains FDA Approval for Use in Narrowed Iliac ArteriesFDA Panel Gives Unanimous Nod to First DES for PADEmbolic Protection Device Lands CE Mark
CLINICAL NEWS
ISAR-REACT 4: Outcomes Similar for Bivalirudin vs. Abciximab-Heparin ComboCPORT-E: On-Site Cardiac Surgery Capability Did Not Influence Elective Angioplasty ResultsConsequences of 30-Day Readmission After PCI Found Dire at 1 YearUse of Stress Imaging After Revascularization Highly Dependent on Billing MethodRandomized Trial to Compare BVS with EES in Patients with CADLong-Term Outcomes Encouraging for High-Risk Patients Undergoing TAVRSuboptimal Transfer Times Reported for Most Patients Needing PCIGenetic, Drug-Related Factors May Play Role in Early Stent Thrombosis ACC, STS Launch US TAVR RegistryUpdated PCI Guidelines: ‘Most Evidence-Based to Date’Phase 3 Trial Underway to Test Ranolazine in Patients After PCIOutcomes Comparable for PCI vs. CABG in Left Main CAD
FEATURE
Weighing Revascularization Options in Multivessel Disease
INTERVENTION RX
Cangrelor: A Novel Treatment for Bridging Antiplatelet Therapy in Patients Undergoing Surgery
CTO CORNER
The Why and How of CTO Interventions
THE TAKE HOME
The Take Home: TCT
5 QUESTIONS WITH DR. BHATT
A Conversation with Howard C. Herrmann, MD
« Previous Issue